Bioprocessing and biotechnology exploit microorganisms (such as bacteria) for the production of chemicals, biologics, therapies, and food. A major unmet challenge is that bacteriophage (phage) contamination compromises products and necessitates shut-downs and extensive decontamination using nonspecific disinfectants. Here we demonstrate that poly(acrylic acid) prevents phage-induced killing of bacterial hosts, prevents phage replication, and that induction of recombinant protein expression is not affected by the presence of the polymer. Poly(acrylic acid) was more active than poly(methacrylic acid), and poly(styrenesulfonate) had no activity showing the importance of the carboxylic acids. Initial evidence supported a virustatic, not virucidal, mechanism of action. This simple, low-cost, mass-produced additive offers a practical, scalable, and easy to implement solution to reduce phage contamination.I t is now possible to edit biosynthetic pathways in bacteria to produce high-value chemicals and natural products. 1 Bacteria are widely used in food production. For bacteria to be used in any application area, it is essential to exclude bacteriophage (phage−bacteria selective viruses), which are a common cause of infection that leads to financial and scientific losses. Bacteriophages are among the most abundant organisms on earth and are present wherever their hosts are. 2 Phages have potential as alternatives to antibiotics 3−5 for food safety 6 and veterinary settings. 7 Phages are also widely used in biotechnology for ligand selection 8−10 and other areas. 8,11 Despite their wide biotechnological use, phage contamination in bacterial cultures leads to a complete loss of the culture. This has significant cost implications for both academic and industrial laboratories that have invested in isolating and preparing these bacterial cultures. For example, in the food industry, it is not possible to remove all phage from raw materials, and this can lead to process collapse. 12−14 Currently, good microbiology practice, aseptic conditions, and vigorous cleaning or autoclaving are the primary mitigation tools. These methods are not always successful, as phages are robust and can survive in almost every condition. 15 One option is to engineer bacterial strains, which are intrinsically resistant to phage, using, for example, gene editing technology, but this is not trivial and might not be suitable for all hosts. 16 Changing processes or re-engineering strains that have been optimized for a particular biorefinery challenge is not simple: a pragmatic solution would be an antiphage additive, in much the same way that antibiotics are routinely used in mammalian cell culture, to prevent bacterial infection. 17 There are many studies on the use of phage in treatment 7,18,19 and for ligand screening, 9,10,20 but very few on tools to inhibit them. In contrast, mammalian viruses have been investigated for the discovery of viral inhibitors 21,22 and for repurposing of existing inhibitors. 23